Bromocriptine mesylate: FDA-approved novel treatment for type-2 diabetes

» Next article

» Previous article

» Table of Contents

» Similar in PUBMED

» Search Pubmed for

» Search in Google Scholar for

» Citation Manager

» Access Statistics

» Reader Comments

» Email Alert *

* Requires registration (Free)

Click on image for details.

SHORT COMMUNICATION

Year : 2009 | Volume : 41 | Issue : 4 | Page : 197-198

Bromocriptine mesylate: FDA-approved novel treatment for type-2 diabetes

Rajiv Mahajan
Department of Pharmacology, AIMSR, Bhatinda, India

Correspondence Address:
Rajiv Mahajan
Department of Pharmacology, AIMSR, Bhatinda
India

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0253-7613.56070

[FULL TEXT] [PDF]*

Online since 20^th July '04

Published by Wolters Kluwer - Medknow